(Q55009101)

15 June 2018

title

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer. (English)

1 reference

15 June 2018

12

Rie Horii

1 reference

15 June 2018

Norikazu Masuda

5

object named as

Norikazu Masuda

1 reference

15 June 2018

author name string

Hiroko Yamashita

1

1 reference

15 June 2018

Akiko Ogiya

2

1 reference

15 June 2018

Tadahiko Shien

3

1 reference

15 June 2018

Yoshiya Horimoto

4

1 reference

15 June 2018

Touko Inao

6

1 reference

15 June 2018

Tomofumi Osako

7

1 reference

15 June 2018

Masato Takahashi

8

1 reference

15 June 2018

Yumi Endo

9

1 reference

15 June 2018

Mitsuchika Hosoda

10

1 reference

15 June 2018

Naoko Ishida

11

1 reference

15 June 2018

Kieko Yamazaki

13

1 reference

15 June 2018

Yuichiro Miyoshi

14

1 reference

15 June 2018

Hiroyuki Yasojima

15

1 reference

15 June 2018

Nobumoto Tomioka

16

1 reference

15 June 2018

Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society

17

1 reference

15 June 2018

publication date

14 October 2015

1 reference

15 June 2018

published in

Breast Cancer

1 reference

15 June 2018

volume

23

1 reference

15 June 2018

issue

6

1 reference

15 June 2018

page(s)

830-843

1 reference

15 June 2018

https://scigraph.springernature.com/pub.10.1007/s12282-015-0649-0

exact match

0 references

cites work

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Markers for the identification of late breast cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Factors predicting late recurrence for estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Menopausal status should be taken into consideration for patients with luminal a breast cancer in terms of the effect of differential biology on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

The molecular landscape of premenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Qualitative age interactions in breast cancer studies: mind the gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-015-0649-0

10.1007/S12282-015-0649-0

21 January 2018

Identifiers

DOI

1 reference

15 June 2018

Dimensions Publication ID

1022349191

0 references

1 reference

15 June 2018